glp 1 agonist for type 1 diabetes glp-1_analogs [TUSOM Weight-Loss Drug Use Has Risen

Formulation and Administration GLP-1 agonists are available in various formulations, including injectable and oral medications

In contrast, this study applied stricter inclusion criteria, restricting the analysis to large randomised cardiovascular outcome trials with a minimum sample size of 3000 participants and a minimum follow-up of at least 12 months

Vision changes GLP-1s can affect the vision in several ways, including worsening vision in some cases due to rapid blood sugar correction or insufficient blood flow to the optic nerve

Bloating and increased gas are also reported during the first few weeks

The burping and nausea patterns common with GLP-1 agonists often respond well to dose reduction and slower titration

Spichak, S